Kastus funding is a shot in the arm

An Irish firm whose product will be central in the fight against antibiotic-resistant superbugs last week received a €1.5m investment to underpin its plans for global expansion.

The scientific invention developed by Kastus Technologies could be central to stemming the global spread of bacterial infections that are predicted to kill millions worldwide within the next thirty years.

The investment by the Atlantic Bridge University Fund will enable the core technologies developed at the Dublin Institute of Technology’s Centre for Research in Engineering Surface Technology enter the commercial marketplace in the near future.